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Abstract
Lethal acrodermatitis (LAD) is a genodermatosis with monogenic autosomal recessive
inheritance in Bull Terriers and Miniature Bull Terriers. The LAD phenotype is character-
ized by poor growth, immune deficiency, and skin lesions, especially at the paws. Utilizing
a combination of genome wide association study and haplotype analysis, we mapped the
LAD locus to a critical interval of ~1.11 Mb on chromosome 14. Whole genome sequenc-
ing of an LAD affected dog revealed a splice region variant in the MKLN1 gene that was
not present in 191 control genomes (chr14:5,731,405T>G or MKLN1:c.400+3A>C). This
variant showed perfect association in a larger combined Bull Terrier/Miniature Bull Terrier
cohort of 46 cases and 294 controls. The variant was absent from 462 genetically diverse
control dogs of 62 other dog breeds. RT-PCR analysis of skin RNA from an affected and
a control dog demonstrated skipping of exon 4 in the MKLN1 transcripts of the LAD affec-
ted dog, which leads to a shift in the MKLN1 reading frame. MKLN1 encodes the widely
expressed intracellular protein muskelin 1, for which diverse functions in cell adhesion,
morphology, spreading, and intracellular transport processes are discussed. While the
pathogenesis of LAD remains unclear, our data facilitate genetic testing of Bull Terriers
and Miniature Bull Terriers to prevent the unintentional production of LAD affected dogs.
This study may provide a starting point to further clarify the elusive physiological role of
muskelin 1 in vivo.
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Author summary
Lethal acrodermatitis (LAD) is an autosomal recessive hereditary disease in dogs. It is
characterized by poor growth, immune deficiency and characteristic skin lesions of
the paws and of the face. We mapped the LAD locus to a ~1.11 Mb segment on canine
chromosome 14. Whole genome sequence data of an LAD affected dog and 191 con-
trols revealed a candidate causative variant in the MKLN1 gene, encoding muskelin 1.
The identified variant, a single nucleotide substitution, MKLN1:c.400+3A>C, altered
the 5’-splice site at the beginning of intron 4. We experimentally confirmed that this
variant leads to complete skipping of exon 4 in the MKLN1 mRNA in skin. Various
cellular functions have been postulated for muskelin 1 including roles in intracellular
transport processes, cell morphology, cell spreading, and cell adhesion. Our data from
dogs reveal a novel in vivo role for muskelin 1 that is related to the immune system and
skin. MKLN1 thus represents a novel candidate gene for human patients with unsolved
acrodermatitis and/or immune deficiency phenotypes. LAD affected dogs may serve as
models to gain more insights into the function of muskelin 1.
Introduction
Acrodermatitis enteropathica in humans (OMIM #201100) is an inherited disorder of zinc
metabolism. Affected patients display an inflammatory rash, diarrhea and a general failure to
thrive [1–3]. This disease is caused by variants in the SLC39A4 gene encoding a zinc trans-
porter that mediates the uptake of dietary zinc in the gut. Clinical signs in patients will amelio-
rate or even resolve upon oral supplementation with zinc [4]. A similar SLC39A4 associated
hereditary zinc deficiency exists in cattle [5].
In Bull Terriers, a related phenotype termed lethal acrodermatitis (LAD) has been reported
in the scientific literature as early as 1986 [6]. LAD is inherited as a monogenic autosomal
recessive trait. Affected puppies show characteristic skin lesions on the feet and on the face,
diarrhea, bronchopneumonia, and a failure to thrive. The skin lesions consist of erythema and
tightly adherent scales, erosions or ulcerations with crusts involving primarily the feet, distal
limbs, elbows, hocks, and muzzle. Later on, hyperkeratosis of the footpads and deformation of
the nails occur. LAD affected dogs also show a coat color dilution in pigmented skin areas. An
abnormally arched hard palate impacted with decayed, malodorous food is a characteristic
clinical marker for the disease (Fig 1) [6–8].
LAD dogs are immunodeficient with a reduction in serum IgA levels and frequently suffer
from skin infections with Malassezia or Candida [9,10]. LAD manifests clinically in the first
weeks of life. Affected puppies typically die before they reach an age of two years, either due to
infections such as bronchopneumonia or because they are euthanized when their paw pad
lesions become very severe and painful. They grow slower than their non-affected littermates
and at the age of one year have about half the body weight and size of an unaffected dog [8].
Some, but not all studies found reduced levels of zinc in the serum of LAD affected dogs
[6,8,11]. In contrast to acrodermatitis enteropathica in humans, oral or intravenous supple-
mentation of zinc does not lead to an improvement of the clinical signs in LAD affected dogs
[6]. A proteomic analysis reported changes related to inflammatory response in the liver of
LAD affected puppies [12].
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Fig 1. LAD phenotype. (A) Inflammatory skin lesions in the face of an affected Bull Terrier. (B) Similar lesions in the inguinal region. (C)
LAD affected puppy in the middle of two non-affected littermates. A pronounced growth delay and a subtle coat color dilution are visible. (D,
E) Fore paws of an LAD affected Bull Terrier puppy at necropsy. Symmetrical scaling and crusting of the skin including interdigital areas and
foot pads is visible (F, G) Histopathological micrographs of the junction of interdigital haired skin and digital pad from an affected Bull Terrier
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In the present study, we performed a genome-wide association study (GWAS) followed by
a whole genome sequencing approach to unravel the causative genetic variant for LAD in Bull
Terriers and Miniature Bull Terriers.
Results
Mapping of the LAD locus
We performed a GWAS with genotypes from 78 Bull Terriers and Miniature Bull Terriers.
After quality control, the pruned dataset consisted of 22 LAD cases, 48 controls and 76,419
markers. We obtained a single strong association signal with 57 markers exceeding the Bonfer-
roni-corrected genome-wide significance threshold after adjustment for genomic inflation
(PBonf. = 6.5 x 10
−7). All significantly associated markers were located on chromosome 14
within an interval spanning from 0.9 Mb– 10.6 Mb. The three top-associated markers all had a
P-value of 1.4 x 10−9 and were located between 5.2 Mb– 5.9 Mb on chromosome 14 (Fig 2).
To narrow down the identified region, we visually inspected the genotypes of the cases to
perform autozygosity mapping. We searched for homozygous regions with allele sharing and
found one region of ~1.11 Mb, which was shared between all 22 cases. The critical interval for
the causative LAD variant corresponded to the interval between the first flanking heterozygous
markers on either side or chr14:5,248,244–6,355,383 (CanFam 3.1 assembly).
Identification of a candidate causative variant
We sequenced the genome of an affected Bull Terrier at 24x coverage and called single nucleo-
tide variants (SNVs) and small indel variants with respect to the reference genome (CanFam
3.1). We then compared these variants to whole genome sequence data of 3 wolves and 188
control dogs from genetically diverse breeds. This analysis identified five private homozygous
variants in the critical interval in the affected dog (Table 1, S1 Table).
Four of these five variants were intergenic and classified as “modifier” by the SNPeff soft-
ware. The remaining fifth variant was located within the 5’-splice site of intron 4 of the
MKLN1 gene and its SNPeff impact prediction was “low”. The formal designation of this vari-
ant is chr14:5,731,405T>G or MKLN1:c.400+3A>C (S1 Fig).
We confirmed the presence of this variant by Sanger sequencing (Fig 3). As MKLN1:c.400+3A>C
represented the only plausible candidate causative variant, we genotyped 251 Bull Terriers, 89
Miniature Bull Terriers, and 462 dogs from 62 other breeds for this variant (Table 2). The var-
iant showed perfect association with the LAD phenotype in Bull Terriers and Miniature Bull
Terriers (PFisher = 4.8 x 10
−58). All 46 available cases were homozygous for the variant, whereas
the unaffected dogs were either homozygous wildtype or heterozygous. The test dogs included
a subset of unaffected Bull Terriers and Miniature Bull Terriers from Finland, which were not
specifically collected for this study and therefore considered representative for the general
population. The 166 Finnish dogs contained 37 heterozygous dogs (22%). The variant was not
found in any of the tested dogs from other breeds.
Functional confirmation
To assess the putative impact of the MKLN1 variant on splicing, we analyzed the frequency of the
wildtype and mutant sequence motifs in a compilation of 186,630 human 5’-splice sites [13,14].
The canine wildtype sequence TAGgtaagg was identical to the sequence of 276 human 5’-splice
puppy (F) and a control dog (G). Marked thickening of the epidermis, excessive layers of non-cornifying epithelium and a large pustule are
evident in the affected dog. Hematoxylin-eosin, bar = 400 µm.
https://doi.org/10.1371/journal.pgen.1007264.g001
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Fig 2. Mapping of the LAD locus. (A) A GWAS was performed in a cohort of 22 LAD cases and 48 controls. The
Manhattan plot shows a single significant signal at the beginning of chromosome 14. The red line indicates the
Bonferroni significance threshold (PBonf = 6.5 x 10
-7). The quantile-quantile (QQ) plot in the inset shows the observed
versus expected–log(p) values. The straight red line in the QQ plot indicates the distribution of p-values under the null
hypothesis. The deviation of p-values at the right side indicates that these markers are stronger associated with the trait
than it would be expected by chance. (B) Haplotype analysis in the 22 LAD cases. Each horizontal bar represents the
chromosome 14 haplotypes of one dog. Twenty Bull Terriers and two Miniature Bull Terriers (MBT) had large
homozygous intervals with allele sharing on chromosome 14 indicated in blue. The homozygous haplotype segment
shared between all 22 dogs spanned ~1.11 Mb. The critical interval for the causative LAD variant corresponded to the
interval between the first flanking heterozygous markers on either side or chr14:5,248,244–6,355,383 (CanFam 3.1
assembly). (C) Gene annotation for the critical interval. The NCBI annotation release 105 listed 4 protein coding genes
(indicated in black or red) and 11 genes for non-coding RNAs (indicated in blue).
https://doi.org/10.1371/journal.pgen.1007264.g002
Table 1. Variants detected by whole genome re-sequencing of an LAD affected dog.
Filtering stepa Number of variants
Homozygous variants in the whole genome 3,061,192
Homozygous variants in the 1.11 Mb critical interval on chromosome 14 1,445
Private homozygous variants (absent from 191 control genomes) in critical interval 5
a The sequences were compared to the reference genome (CanFam 3.1) from a Boxer.
https://doi.org/10.1371/journal.pgen.1007264.t001
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sites, while the mutant sequence motif TAGgtcagg occurred in only 3 human 5’-splice sites. The
very low frequency of the mutant sequence motif suggested that MKLN1:c.400+3A>C might
affect the efficacy of the splicing process. Several other pathogenic A>C transversions at 5’-splice
sites’ position +3 with subsequent exon skipping have been described in the literature [15–17].
We experimentally analyzed MKLN1 transcripts in skin RNA from an LAD affected dog
with the homozygous mutant C/C genotype in comparison to a healthy control dog (A/A
genotype). RT-PCR with primers located at the exon 2/3 and exon 5/6 boundaries yielded a
cDNA fragment of the expected size in the control dog, but not in the LAD affected dog. In the
LAD affected dog, a very clean cDNA amplicon lacking exon 4 was obtained. This experiment
demonstrated a complete skipping of exon 4 in MKLN1 transcripts as consequence of the
genomic MKLN1:c.400+3A>C variant (r.312_400del89; Fig 4). If translated, the mutant tran-
script was predicted to result in a severely truncated protein containing only the first 105 of a
total of 735 amino acids of the wildtype protein (p.(Gly105SerfsTer10); S2 Fig).
Fig 3. Sanger confirmation of theMKLN1:c.400+3A>C variant. (A) Electropherograms from dogs with the three
different genotypes. (B) Wildtype and mutant allele compared to the consensus sequence for the human U2 GT-AG
type 5’-splice sites [13]. Subscript numbers in the consensus sequence indicate the percentage of the respective
conserved nucleotide in 183,682 investigated human 5’-splice site motifs of the U2 GT-AG type. The additional
difference to the optimal consensus in the U1 spliceosomal RNA recognition site in the mutant allele is highlighted in
red. In human 5’-splice sites the most frequent base at position 3 is an A (60%). G is also common at this position
(35%), while C and T are both rare (<3%) [13].
https://doi.org/10.1371/journal.pgen.1007264.g003
Table 2. Association of theMKLN1:c.400+3A>C genotype with the LAD phenotype.
MKLN1:c.400+3A>C genotype A/A A/C C/C
Cases, Bull Terrier (n = 41) - - 41
Cases, Miniature Bull Terrier (n = 5) - - 5
Controls, Bull Terrier (n = 210) 132 78 -
Controls, Miniature Bull Terrier (n = 84) 59 25 -
Controls, other breeds (n = 462) 462 - -
https://doi.org/10.1371/journal.pgen.1007264.t002
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Discussion
In the present study we identified a splice defect in the canine MKLN1 gene in Bull Terriers
with LAD. The combination of GWAS and haplotype analysis localized the causative variant
to a relatively small chromosomal region with only a few characterized genes including
MKLN1. The splice region variant in MKLN1 was the only plausible variant within this critical
interval that showed the expected genotype concordance with the LAD phenotype in a large
cohort of more than 300 Bull Terriers and ~500 dogs from other breeds.
The identified MKLN1:c.400+3A>C variant resulted in exon 4 skipping and a frameshift as
89 nucleotides were missing from the mutant transcripts. It therefore seems likely that mutant
transcripts are degraded by nonsense-mediated mRNA decay. Considering the strong genetic
association of the variant with the phenotype and the fact that we demonstrated a functional
defect on the MKLN1 transcript level, we think that our data strongly suggest the causality of
the MKLN1:c.400+3A>C variant for LAD in Bull Terriers and Miniature Bull Terriers.
MKLN1 encodes the widely expressed intracellular protein muskelin 1, also known as
TWA2. The function of muskelin 1 is only partially understood. It was originally described as
Fig 4. Experimental verification of theMKLN1 splice defect. (A) The genomic organization of the MKLN1 gene.
Exons 2–6 are enlarged and the position of the primers used for RT-PCR is indicated. (B) RT-PCR was performed
using skin cDNA from a control and an LAD affected Bull Terrier. The picture shows a Fragment Analyzer gel image
of the experiment. In the control animal, only the expected 366 bp product is visible. In the LAD affected dog, a 277 bp
product representing a transcript lacking exon 4 is visible. The identity of the bands was verified by Sanger sequencing.
Thus, the MKLN1:c.400+3A>C variant leads to complete skipping of exon 4 (MKLN1:r.312_400del89).
https://doi.org/10.1371/journal.pgen.1007264.g004
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a protein that mediates adhesive and cell-spreading responses to thrombospondin 1, an extra-
cellular matrix adhesion molecule [18]. However, different studies suggested that the function
of muskelin 1 goes beyond this pathway and are also supported by the fact that muskelin 1,
which has homologs in invertebrates and even fission yeast, evolved earlier than the verte-
brate-specific thrombospondin 1 [19,20]. Muskelin 1 is a multidomain protein with an N-ter-
minal discoidin domain, a LisH / CTLH tandem domain, and six C-terminal Kelch repeats,
which forms homotetramers [21]. The LisH domain was shown to be crucial for muskelin 1
dimerization and cytoplasmic localization, and, together with the head-to-tail interaction via
the discoidin domain, also for the tetramerization of muskelin 1 [20,21].
Consistent with its multidomain structure and ubiquitous expression, diverse binding part-
ners have been reported for muskelin 1. It binds prostaglandin EP3 receptor isoform α [22]
and heme-oxidase 1, which counteracts inflammatory and reactive oxygen species induced
damage [23]. It is part of the CTLH complex, the homolog of yeast E3 ubiquitin ligase, where
it binds to RanBPM and Twa I [24–26] and interacts with the cardiogenic transcription factor
TBX-20 [27]. In the rat lens, muskelin 1 is a substrate of Cdk5 and interacts with the Cdk5 acti-
vator p39 [28]. Also in lens, it was shown that p39 links muskelin 1 to myosin II and stress
fibers [29].
Mkln1-/- knockout mice are viable and do not have skin lesions comparable to those in Bull
Terriers with LAD. However, they exhibit a subtle coat color dilution phenotype similar to
that seen in LAD affected dogs. In these Mkln1-/- knockout mice, muskelin 1 was identified as
a protein required for GABAA receptor endocytosis and trafficking in neurons via direct inter-
action with the α1 subunit of GABAA receptors and the motor proteins dynein and myosin
VI. The dilute coat color of Mkln1-/- knockout mice suggested that muskelin is a trafficking
factor involved in several different intracellular transport processes, possibly including mela-
nosome transport [30].
The lacking skin lesions in Mkln1-/- knockout mice raise the questions whether muskelin 1
depletion does not result in disease in mice; whether their clinical signs would only manifest at
a (much) older age; or whether the sterile environment of the laboratory animals prevented
infections and thus the development of skin lesions. In the latter case, LAD would be a primary
immunodeficiency disorder, in agreement with the observation of lower IgA levels and higher
susceptibility to microbial infection in LAD affected dogs [8–10, 12]. Given the diverse known
protein-protein interactions of muskelin 1, it is however likely that absence of muskelin 1 leads
to dysfunctions beyond the immune system.
In humans, an intronic SNV in MKLN1 was associated with urinary potassium excretion
in Korean adults and another intronic MKLN1 SNV with early bipolar disorder [31,32].
Furthermore, MKLN1 has been associated with asthma in independent GWASs. A SNV in
MKLN1 ranked among the top 100 SNVs associated with childhood asthma in a study sam-
ple of 429 affected-offspring trios from a European American population [33]. A different
SNV in the 5’-UTR of MKLN1 was associated with asthma in a population including
patients with severe or difficult-to-treat asthma [34].
In the ExAC database, only one MKLN1 missense, but no nonsense, frameshift or splice site
variants present in a homozygous state were found [35,36]. Furthermore, the probability of
loss of function (LoF, specified as nonsense, splice acceptor, and splice donor variants) toler-
ance was estimated to be 1.00, indicating that the MKLN1 gene is extremely LoF intolerant
[37]. Therefore, it is conceivable that loss of function variants on both alleles might lead to
severe phenotypes in humans.
To our knowledge, no link between muskelin 1 and zinc or copper metabolism has been
reported to date. While acrodermatitis enteropatica in humans and acrodermatitis in cattle
clinically resemble LAD in dogs, these diseases may be caused by completely different
MKLN1 variant in dogs with lethal acrodermatitis
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molecular mechanisms. The fact that findings on zinc levels in the few published studies on
LAD affected dogs were contradictory and zinc supplementation did not lead to improve-
ment of lesions [6] support this hypothesis.
In conclusion, we identified the MKLN1:c.400+3A>C variant leading to a splice defect in
the MKLN1 gene as candidate causative variant for LAD in Bull Terriers and Miniature Bull
Terriers. The molecular pathogenesis of LAD remains unclear. Our data facilitate genetic test-
ing of Bull Terriers and Miniature Bull Terriers to prevent the unintentional breeding of LAD
affected dogs. LAD affected dogs may serve as models to further clarify the elusive physiologi-
cal role of muskelin 1 in vivo.
Materials and methods
Ethics statement
All animal experiments were performed according to the local regulations. The dogs in this
study were examined with the consent of their owners. The study was approved by the “Can-
tonal Committee For Animal Experiments” (Canton of Bern; permits 22/07, 23/10, and 75/16).
Animals and samples
Bull Terriers with their characteristic egg-shaped head were founded as a dog breed in the
1850s in the United Kingdom. Originally, there were no size standards in this breed and
smaller dogs were bred as a variety of the regular Bull Terrier. Eventually, two sub-populations
formed and the Miniature Bull Terrier with a maximum height of 35.5 cm was recognized as
an independent breed in 1991 by the American Kennel Club (AKC) and in 2011 by the Euro-
pean Fe´de´ration Cynologique Internationale (FCI). Therefore, Bull Terriers and Miniature
Bull Terriers share a common ancestral gene pool, but represent independent closed popula-
tions today.
This study included samples from 251 Bull Terriers (41 LAD cases / 210 controls) and 89
Miniature Bull Terriers (5 LAD cases / 84 controls). Case/controls status was based on owners’
reports. We additionally used 462 dogs from 62 breeds, which were assumed to be free of the
disease allele (S3 Table). Skin biopsies were taken from two LAD affected Bull Terriers from toe,
nose, lip, and forearm and fixed in 10% buffered formalin for 24 hours. Biopsies were processed,
embedded in paraffin and sectioned at 4 µm. Skin sections were stained with hematoxylin and
eosin. The histopathology was performed by veterinary pathologists (BR, Dipl.-ECVP, and SH).
Two further biopsies from comparable sites of the same dogs were submerged in RNAlater solu-
tion for subsequent RNA isolation.
DNA isolation and SNV genotyping
We isolated genomic DNA from EDTA blood samples. Seventy-eight dogs were genotyped for
either 173,662 or 218,256 SNVs on the illumina canine_HD chip. The raw SNV genotypes are
available at https://www.animalgenome.org/repository/pub/BERN2017.1208/.
GWAS
The initial dataset consisted of 78 dogs and 220,853 markers. Using Plink version 1.9 [38] we
excluded markers that were not located on autosomes or the X chromosome (n = 2,327) and
markers with a genotyping rate lower than 90% (n = 49,814). Using the R package GenABEL
[39] and the command “check.markers”, dogs with a call rate< 90% (n = 3), ibs> 95% (n = 0),
high individual heterozygosity (FDR = 0.01) (n = 1, included in dogs with low call rate) as well
as markers with a maf< 1% (n = 55,931) and a genotyping rate< 90% (n = 10,951) were
MKLN1 variant in dogs with lethal acrodermatitis
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excluded. Five outliers in the multidimensional scaling plot based on a genomic distance matrix
were also removed. In a second quality control step, markers deviating from Hardy-Weinberg
equilibrium (FDR = 0.2) in controls (n = 1,239), markers with a genotyping rate< 90% (n = 0)
and maf< 1% (n = 26,215) were excluded, resulting in a final dataset of 70 dogs (22 cases, 48
controls) and 76,419 markers. A polygenic model of the hglm package [40], with a kinship
matrix based on autosomal markers in the cleaned dataset as random effect, was estimated and
a score test for association using the function “mmscore” was performed. The genomic inflation
factor was 1.16. We corrected for multiple testing using Bonferroni correction with a signifi-
cance level of 0.05. QQ plots were created using qqman version 0.1.4 [41].
Haplotype analysis
We visually inspected plink tped files for the region of interest on chromosome 14 using Excel
and searched for homozygous regions with haplotype sharing in cases with a call rate >90%.
The first flanking heterozygous markers on either side of the homozygous region in 22 cases
defined the borders of the critical interval.
Whole genome sequencing of an affected Bull Terrier
An Illumina PCR-free TruSeq fragment library with 350 bp insert size of an LAD affected Bull
Terrier was prepared. We collected 219 million 2 x 150 bp paired-end reads or 24x coverage on
a HiSeq3000 instrument. The reads were mapped to the dog reference genome assembly Can-
Fam3.1 and aligned using Burrows-Wheeler Aligner (BWA) version 0.7.5a [42] with default set-
tings. The generated SAM file was converted to a BAM file and the reads were sorted by
coordinate using samtools [43]. Picard tools (http://sourceforge.net/projects/picard/) was used
to mark PCR duplicates. To perform local realignments and to produce a cleaned BAM file, we
used the Genome Analysis Tool Kit (GATK version 2.4.9, 50) [44]. GATK was also used for
base quality recalibration with canine dbsnp version 139 data as training set. The sequence data
were deposited under the study accession PRJEB16012 and sample accession SAMEA4504844
at the European Nucleotide Archive.
Variant calling
Putative SNVs were identified in each of 192 samples (S2 Table) individually using GATK Hap-
lotypeCaller in gVCF mode [45]. Subsequently all sample gVCF files were joined using Broad
GenotypeGVCFs walker (-stand_emit_conf 20.0; -stand_call_conf 30.0). Filtering was per-
formed using the variant filtration module of GATK using the following standard filters: SNVs:
Quality by Depth: QD< 2.0; Mapping quality: MQ< 40.0; Strand filter: FS> 60.0; Mapping-
QualityRankSum: MQRankSum < -12.5; ReadPosRankSum < -8.0. INDELs: Quality by Depth:
QD< 2.0; Strand filter: FS> 200.0. The functional effects of the called variants were predicted
using SnpEFF software [46] together with the NCBI annotation release 104 on CanFam 3.1. For
the filtering of candidate causative variants in the case, we used 191 control genomes, which
were either publicly available [47] or produced during other projects of our group or contrib-
uted by members of the Dog Biomedical Variant Database Consortium. A detailed list of these
control genomes is given in S2 Table.
Gene analysis
We used the dog CanFam 3.1 reference genome assembly for all analyses. Numbering within
the canine MKLN1 gene corresponds to the accessions XM_005628367.3 (mRNA) and
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XP_005628424.1 (protein). Numbering within the human MKLN1 gene corresponds to the
accessions NM_013255.4 (mRNA) and NP_037387.2 (protein).
Sanger sequencing
We used Sanger sequencing to confirm the candidate variant MKLN1:c.400+3A>C and to
genotype the dogs in this study. A 797 bp fragment containing the variant was PCR ampli-
fied from genomic DNA using AmpliTaq Gold 360 Master Mix (Life Technologies) and the
primers CCATGCACTGTAGCCACATC and TGGAAAAGGTTCCACTTGAAAT. After
treatment with shrimp alkaline phosphatase and endonuclease I, PCR products were
directly sequenced on an ABI 3730 capillary sequencer (Life Technologies). We analyzed
the Sanger sequence data using the software Sequencher 5.1 (GeneCodes).
RNA isolation and RT-PCR
RNA was extracted from skin samples using the RNeasy Fibrous Tissue Mini Kit (Qiagen).
The tissue was first finely crushed by mechanical means using TissueLyser (Quiagen), and
RNA was extracted by centrifugation following the instructions by the manufacturer. Total
mRNA was reverse transcribed into cDNA using the SuperScript IV Reverse Transcriptase kit
(Thermo Fisher) with oligo d(T) primers. A PCR on the synthesized cDNA was carried out
using primer MKLN1_c_F2, CCTCCCCAGTACTTGATTCTG, located at the boundary of
exons 2 and 3, and primer MKLN1_c_R2, TTCCTGTTCACGGTACTTGC, located at the
boundary of exons 5 and 6 of the MKLN1 gene. The products were analyzed on a Fragment
Analyzer capillary gel electrophoresis instrument (Advanced Analytical). The sequence of the
obtained RT-PCR products was confirmed by Sanger sequencing as described above.
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